Skip to main content

New Developments in Biological Markers in Prostate Cancer

  • Conference paper
  • 35 Accesses

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 118))

Abstract

The use of biological markers in the diagnosis and follow-up of patients with prostate cancer was pioneered by the work of Gutman et al. in 1936. In the intervening 50 years refinements in techniques and in the understanding of the physiological function of these normally occurring enzymes and proteins have enabled us to understand the potential and the problems associated with the use of these markers in clinical medicine. A review of biological markers in the prostate published previously by me (Pontes 1983) gave an extensive analysis of the value of specific and nonspecific markers in prostate cancer.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Chan DW, Bruzek D, Rock R, Waldron C (1986) evaluation of a monoclonal immunoradiometric assay for prostate-specific antigen. Clin Chem 32: 1125

    Google Scholar 

  • Gutman E, Sproul E, Gutman A (1936) Significance of increased phosphatase activity of bone at the site of osteoplastic metastases secondary to carcinoma of the prostate gland. Am J Cancer 28: 485

    CAS  Google Scholar 

  • Liedtke RJ, Batjer JD (1984) Measurement of prostate-specific antigen by radioimmunoassay. Clin Chem 30: 649–652

    PubMed  CAS  Google Scholar 

  • Oesterling JE, Chan DW, Epstein JI, Kimball AW, Bruzek DJ, Rock RC, Brendler CB Walsh PC (1987) Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. J Urol 139: 766

    Google Scholar 

  • Pontes JE (1983) Bological markers in prostate cancer. J Urol 130: 1037

    PubMed  CAS  Google Scholar 

  • Pontes JE, Jabalameli P, Montie J, Foemmel R, Howard PD; Boyett J (to be published), Disappearance rate of biological markers following radical prostatectomy —prognostic implications. Urology (to be published)

    Google Scholar 

  • Stamey TA, Yang N, Hay AR, McNeal JE, Freiha F, Redwine E (1987) Prostate specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 317: 909

    Article  PubMed  CAS  Google Scholar 

  • Vihko PM, Schroeder FH, Lukkarinen O, Vihko R (1982) Secretion into and elimination from blood circulation of prostate specific acid phosphatase, measured by radioimmunoassay. J Urol 128: 202

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag Berlin·Heidelberg

About this paper

Cite this paper

Pontes, J.E. (1990). New Developments in Biological Markers in Prostate Cancer. In: Beck, L., Grundmann, E., Ackermann, R., Röher, HD. (eds) Hormone-Related Malignant Tumors. Recent Results in Cancer Research, vol 118. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83816-3_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-83816-3_18

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-83818-7

  • Online ISBN: 978-3-642-83816-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics